Work

Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.12680

Authors: A. Dutour, I. Abdesselam, P. Ancel, F. Kober, G. Mrad, P. Darmon, O. Ronsin, V. Pradel, N. Lesavre, J. C. Martin, A. Jacquier, Y. Lefur, M. Bernard, B. Gaborit

Institutions: Inserm, Aix-Marseille Université, Institut National de la Recherche Agronomique, Centre National de la Recherche Scientifique, Centre de Résonance Magnétique Biologique et Médicale, Assistance Publique Hôpitaux de Marseille, Hôpital Sainte-Marguerite, Hôpital Nord, Hôpital de la Timone

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2337473245

FWCI: 11.19

Cites: 51

Cited by: 263

Related to: 10